Pyrrolo[3,4-c]- -carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase

By Teller S.   Eluwa S.   Koller M.   Uecker A.   Beckers T.   Baasner S.   Bohmer F.-D.   Mahboobi S.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 4, 2000-04 ,pp. : 413-427

Elsevier

Access to resources Recommend Favorite

Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

By Criscitiello Carmen   Gelao Lucia   Viale Giulia   Esposito Angela   Curigliano Giuseppe  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 599-610

Informa Healthcare

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

By  

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 653-681

Bentham Science Publishers

Access to resources Recommend Favorite